Alvente, S.; Matteoli, G.; Molina-Porcel, L.; Landa, J.; Alba, M.; Bastianini, S.; Berteotti, C.; Graus, F.; Lo Martire, V.; Sabater, L.;
et al. Pilot Study of the Effects of Chronic Intracerebroventricular Infusion of Human Anti-IgLON5 Disease Antibodies in Mice. Cells 2022, 11, 1024.
https://doi.org/10.3390/cells11061024
AMA Style
Alvente S, Matteoli G, Molina-Porcel L, Landa J, Alba M, Bastianini S, Berteotti C, Graus F, Lo Martire V, Sabater L,
et al. Pilot Study of the Effects of Chronic Intracerebroventricular Infusion of Human Anti-IgLON5 Disease Antibodies in Mice. Cells. 2022; 11(6):1024.
https://doi.org/10.3390/cells11061024
Chicago/Turabian Style
Alvente, Sara, Gabriele Matteoli, Laura Molina-Porcel, Jon Landa, Mercedes Alba, Stefano Bastianini, Chiara Berteotti, Francesc Graus, Viviana Lo Martire, Lidia Sabater,
and et al. 2022. "Pilot Study of the Effects of Chronic Intracerebroventricular Infusion of Human Anti-IgLON5 Disease Antibodies in Mice" Cells 11, no. 6: 1024.
https://doi.org/10.3390/cells11061024
APA Style
Alvente, S., Matteoli, G., Molina-Porcel, L., Landa, J., Alba, M., Bastianini, S., Berteotti, C., Graus, F., Lo Martire, V., Sabater, L., Zoccoli, G., & Silvani, A.
(2022). Pilot Study of the Effects of Chronic Intracerebroventricular Infusion of Human Anti-IgLON5 Disease Antibodies in Mice. Cells, 11(6), 1024.
https://doi.org/10.3390/cells11061024